Results 211 to 220 of about 94,936 (269)

Advancements in Immunotherapy for Lung Cancer: A Meta‐Analysis of Clinical Trial Outcomes

The Clinical Respiratory Journal, Volume 20, Issue 9, September 2026.
The graphical abstract presents a meta‐analysis of randomized controlled trials (RCTs) associating immune checkpoint inhibitors (ICIs) with or without chemotherapy versus chemotherapy alone for adults with advanced or metastatic non–small cell lung cancer (NSCLC) ABSTRACT Immune checkpoint inhibitors (ICIs) have changed therapeutic selections for ...
Yingjie Jiao, Yan Zhao
wiley   +1 more source

Docetaxel-Induced Serositis Mimicking Malignant Pleural Effusion. [PDF]

Clin Case Rep
Anees M, Chiu K, Goertzen S, Jimenez CA, Faiz SA.   +4 more
europepmc   +1 more source

Eccrine Squamous Syringometaplasia Mimicking Acute Cutaneous GVHD in a Pediatric HSCT Recipient: Case Report and Brief Review of the Indexed Literature

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 792-802, September 2026.
ABSTRACT Eccrine squamous syringometaplasia (ESS) is an uncommon reactive alteration of eccrine ducts, most often reported in oncologic and transplant settings, where it may clinically mimic acute cutaneous graft‐versus‐host disease (GVHD). We describe a 3‐year‐old boy with chronic granulomatous disease who developed a diffuse erythematous eruption 6 ...
Benedetta Galli, Cecilia Catapano, Iacopo Ghini, Mariateresa Rossi, Marina Venturini, Valeria Boccaletti   +5 more
wiley   +1 more source

From Tumour to Bloodstream: Advancing PD‐L1 Testing With Liquid Biopsies in Non‐Small Cell Lung Cancer

Cytopathology, Volume 37, Issue 5, Page 438-448, September 2026.
This review explores liquid biopsy as a complementary approach to tissue‐based PD‐L1 assessment in advanced NSCLC treated with immune checkpoint inhibitors. Focusing on circulating tumour cells, extracellular vesicles, and circulating tumour DNA, it summarises current evidence, technical challenges, and future perspectives for personalised ...
R. Leporati, V. Callegari, A. Ancora, M. Palmieri, B. Riccò, E. Cabitza, L. Trudu, K. Di Emidio, C. Chiavelli, A. Eccher, I. Mastrolia, V. Catani, S. Bettelli, G. Guaitoli, M. Dominici, F. Bertolini   +15 more
wiley   +1 more source

Microtubule regulation in cancer cells. [PDF]

Front Cell Dev Biol
Matov A.
europepmc   +1 more source

Cathepsin V (CTSV) Shapes the Epigenetic–Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker

International Journal of Urology, Volume 33, Issue 9, September 2026.
ABSTRACT Objective The aim of this study was to perform a comprehensive characterization of CTSV regulation in bladder cancer (BC) and its association with clinicopathological features, prognosis, and tumor stroma modulation using multi‐omics databases.
Wallax Augusto Silva Ferreira, Fabio Albuquerque Marchi, Glauco Akelinghton Freire Vitiello, Rolando André Rios Villacis, Ana Paula Drummond Rodrigues, Edivaldo Herculano Correa de Oliveira   +5 more
wiley   +1 more source

Imaging and Clinical Correlates of [¹⁷⁷Lu]Lu-PSMA PET-Defined Eligibility in De Novo Metastatic Prostate Cancer. [PDF]

Biomedicines
Pecoraro G, Cuzzocrea M, Iacovitti CM, Puglisi M, Martinello C, De Giorgi A, Merler S, Tortola L, Lin HM, Leone G, Turco F, Mestre RP, Treglia G, Vogl U, Gillessen S, Pedrani M, Paone G.   +16 more
europepmc   +1 more source

A succinylation-based classifier predicts chemotherapy response in prostate cancer and reveals KAT2A as a therapeutic target. [PDF]

Clin Transl Med
Dong A, Hu W, Lu Z, Li L, Liu K, Feng S, Xie D.   +6 more
europepmc   +1 more source

Prognostic Value of Bcl‐xL in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis

Journal of Oral Pathology &Medicine, Volume 55, Issue 8, Page 885-894, September 2026.
ABSTRACT Background Head and neck squamous cell carcinoma is a heterogeneous disease with poor survival outcomes. Bcl‐xL regulates tumor cell survival and apoptosis and has been associated with metastasis and poor prognosis, although its overall role remains undeciphered.
L. Leinonen, R. Tiikkaja, M. Juola, P. Åström, T. Salo, K. Juurikka, K. Korelin   +6 more
wiley   +1 more source

Comparative effectiveness of intravesical gemcitabine vs. sequential gemcitabine and docetaxel for high-risk nonmuscle-invasive bladder cancer. [PDF]

Urol Oncol
Moyer JA, Ashraf M, Mi L, Zganjar AJ, Lyon TD, Shah PH, Boorjian SA, Tyson MD.   +7 more
europepmc   +1 more source